COVID-19 and bile acids: new perspectives to consider
Keywords:
cholesterol, bile acids, COVID-19Abstract
The lack of control of bile acids, signaling molecules with biological and pleotropic actions associated with the intestinal microbiota, the immune system and energy, lipid, glycemic and cholesterol metabolisms, amplifies the inflammatory response from the hepato-intestinal system to other organs involved with multiple failure and death. To describe their biomolecular evidence as possible metabolomic agents associated with complications of COVID-19, a systematic and critical review of what was published between 2000 and 2020 was carried out on their actions in supraphysiological conditions. These could constitute the theoretical basis that infer the damage of the cholangiolar epithelium by SARS-CoV-2, which favors the toxic action of bile acids, and allows the hypothesis of considering them as constituents of an axis that transverse this inflammatory process, as active participants in each of its stages, therefore, prognostic agents of this disease. Clinical studies are recommended for confirmation.Downloads
Downloads
Published
How to Cite
Issue
Section
License
The journal Anales de la Academia de Ciencias de Cuba protects copyright, and operates with a Creative Commons License 4.0 (Creative Commons Attribution-NonCommercial License 4.0). By publishing in it, authors allow themselves to copy, reproduce, distribute, publicly communicate their work and generate derivative works, as long as the original author is cited and acknowledged. They do not allow, however, the use of the original work for commercial or lucrative purposes.
The authors authorize the publication of their writings, retaining the authorship rights, and assigning and transferring to the magazine all the rights protected by the intellectual property laws that govern in Cuba, which imply editing to disseminate the work.
Authors may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with recognition of having been first published in this journal.
To learn more, see https://creativecommons.org